Dr. Brad Snead Performs One of the First iStent Inject Implants in Fort Myers, FL
FORT MYERS, FL. (September 13, 2018) – Snead Eye Group Medical Director, Dr. Brad A. Snead, M.D., F.A.C.S., is one of the first physicians in Southwest Florida to perform the iStent inject® procedure, which took place at the Fort Myers Eye Surgery Center.
The iStent inject® Trabecular Micro-Bypass System (simply known as the iStent inject®) is for patients with mild to moderate, primary open-angle glaucoma. Glaucoma is a group of vision-threatening eye diseases that can cause damage to the optic nerve, which connects to the brain at the back of the eye. The damage caused by glaucoma is irreversible and, unfortunately, is one of the leading causes of vision loss. Glaucoma is a disease without noticeable symptoms until the patient begins to lose their peripheral vision.
Why Is Dr. Brad Snead’s iStent Inject® Procedure Important?
To help mitigate the effects of glaucoma, the iStent inject® is implanted into the drainage channel of the inside of the eye to enhance better drainage of fluid from inside the eye.
“The iStent inject® during cataract surgery is actually two tiny implants, which make up the world’s smallest medical device implanted in the human body,” explained Dr. Brad A. Snead. “The iStent inject® can make a huge impact for patients who receive it. Once implanted, the device can help restore normal pressure in the eye.”
Founder Dr. John W. Snead added, “The iStent inject® restores your eye’s natural ability to drain the fluid that causes the increased pressure inside your eye and keeps eye pressure at a normal level. These benefits may reduce or eliminate your need for glaucoma medication.”